Mylan execs
Executive Summary
Hal Korman will be president of Mylan's generics subsidiary, Mylan Pharmaceuticals, leaving the top job at Mylan's UDL Laboratories. Korman will report to Lou DeBone, who has been heading the generics division in addition to his role as Mylan chief operating officer. John Deiriggi is named Mylan's first VP-generic business development, with responsibility for generic drug business development at all subsidiaries. Deiriggi has been serving as VP-strategic planning...